Skip to main content

Allan Jonathan's Form 4 filing

Stoke Therapeutics, Inc. (STOK) · filed Sep 3, 2025

Accession no.
0001415889-25-023589
Filed
Sep 3, 2025
Trade date
Aug 29-Sep 3, 2025
Filing delay
5 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $444.9K. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Allan JonathanCIK 0001966716Officer (GENERAL COUNSEL & CORP SEC)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 29, 2025Common StockMOption exerciseAcquired+850$7.07+$6,009.524,798Direct
Aug 29, 2025Common StockSSaleDisposed−850$20.00−$17,00023,948Direct
Sep 2, 2025Common StockMOption exerciseAcquired+9,150$7.07+$64,690.533,098Direct
Sep 2, 2025Common StockSSaleDisposed−14,922$20.14−$300,529.0818,176Direct
Sep 3, 2025Common StockSSaleDisposed−6,345$20.07−$127,344.1511,831Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 29, 2025Common StockMOption exerciseDisposed−850$0.00$024,951Direct
Sep 2, 2025Common StockMOption exerciseDisposed−9,150$0.00$015,801Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)